ChemotherapyFDA-approvedSecond-line
Clofarabine
How it works
Interferes with DNA synthesis, causing cancer cells to die.
Cancer types
Leukemia— All patients
Efficacy
In clinical trials, around 30% of patients achieved a complete remission, with a median overall survival of approximately 15 months.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.